ATE552832T1 - Antidepressivum-propharmaka - Google Patents
Antidepressivum-propharmakaInfo
- Publication number
- ATE552832T1 ATE552832T1 AT07751499T AT07751499T ATE552832T1 AT E552832 T1 ATE552832 T1 AT E552832T1 AT 07751499 T AT07751499 T AT 07751499T AT 07751499 T AT07751499 T AT 07751499T AT E552832 T1 ATE552832 T1 AT E552832T1
- Authority
- AT
- Austria
- Prior art keywords
- antidepressant
- propharmacies
- prodrugs
- prodrug
- conjugated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77621606P | 2006-02-24 | 2006-02-24 | |
PCT/US2007/004743 WO2007100668A2 (en) | 2006-02-24 | 2007-02-22 | Antidepressant prodrugs |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE552832T1 true ATE552832T1 (de) | 2012-04-15 |
Family
ID=38459574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07751499T ATE552832T1 (de) | 2006-02-24 | 2007-02-22 | Antidepressivum-propharmaka |
Country Status (5)
Country | Link |
---|---|
US (1) | US20110136742A1 (de) |
EP (1) | EP1991248B1 (de) |
AT (1) | ATE552832T1 (de) |
CA (1) | CA2643892A1 (de) |
WO (1) | WO2007100668A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8198268B2 (en) | 2008-10-31 | 2012-06-12 | Janssen Biotech, Inc. | Tianeptine sulfate salt forms and methods of making and using the same |
SG11201610547WA (en) * | 2014-06-27 | 2017-01-27 | Kao Corp | Solid composition |
JP2021505595A (ja) | 2017-12-05 | 2021-02-18 | サノビオン ファーマシューティカルズ インクSunovion Pharmaceuticals Inc. | 結晶形およびその製造方法 |
SG11202005016SA (en) | 2017-12-05 | 2020-06-29 | Sunovion Pharmaceuticals Inc | Nonracemic mixtures and uses thereof |
US11160758B2 (en) | 2019-06-04 | 2021-11-02 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3875137A (en) * | 1973-04-20 | 1975-04-01 | Searle & Co | N-Substituted aspactyl peptide amids |
AU710339B2 (en) * | 1994-10-05 | 1999-09-16 | Amarin Neuroscience Limited | Treatment of multiple sclerosis (ms) and other demyelinating conditions using lofepramine in combination with l-phenylalanine, tyrosine or tryptophan and possibly a vitamin b12 compound |
US6716452B1 (en) | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
US7060708B2 (en) | 1999-03-10 | 2006-06-13 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
CA2477038A1 (en) | 2002-02-22 | 2003-09-04 | New River Pharmaceuticals | Use of peptide-drug conjugation to reduce inter-subject variability of drug serum levels |
CA2540678C (en) | 2003-09-30 | 2011-02-22 | New River Pharmaceuticals Inc. | Pharmaceutical compositions for prevention of overdose or abuse |
-
2007
- 2007-02-22 EP EP07751499A patent/EP1991248B1/de not_active Not-in-force
- 2007-02-22 WO PCT/US2007/004743 patent/WO2007100668A2/en active Application Filing
- 2007-02-22 CA CA002643892A patent/CA2643892A1/en not_active Abandoned
- 2007-02-22 AT AT07751499T patent/ATE552832T1/de active
- 2007-02-22 US US12/280,190 patent/US20110136742A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2643892A1 (en) | 2007-09-07 |
EP1991248A4 (de) | 2009-08-05 |
US20110136742A1 (en) | 2011-06-09 |
WO2007100668A3 (en) | 2008-09-12 |
EP1991248B1 (de) | 2012-04-11 |
WO2007100668A2 (en) | 2007-09-07 |
EP1991248A2 (de) | 2008-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118454T1 (el) | Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες | |
EA200802008A1 (ru) | Фармацевтические композиции | |
ATE528989T1 (de) | Kristalline feste rasagilin-base | |
BR112012014082A2 (pt) | composições e métodos que compreendem variantes de protease | |
UY30319A1 (es) | Formulaciones de inhibidores de dpp iv | |
BRPI0710508B8 (pt) | composição de pepticorpo terapêutico liofilizado estável, kit para preparar uma composição farmacêutica aquosa, e métodos para fabricar um pepticorpo terapêutico liofilizado e para preparar uma composição de pepticorpo terapêutico reconstituído | |
NI201000055A (es) | 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa. | |
HN2006011218A (es) | Composiciones de tigeciclina y métodos de preparación | |
ATE502921T1 (de) | Substituierte indole | |
NO20090596L (no) | Antivirale fosfinatforbindelser | |
NO20074823L (no) | Rasagilin-formuleringer med forbedret innholdsensartethet | |
MX2009004862A (es) | Estabilizacion de vacunas por liofilizacion. | |
EA201190306A1 (ru) | Улучшенная липидная композиция | |
EA201170227A1 (ru) | Имидазолкарбоксамиды | |
BRPI1015043A2 (pt) | derivados de diazahomoadamantano e métodos de uso dos mesmos | |
EA201001639A1 (ru) | Композиции и способы их получения и применения | |
GT200600117A (es) | Nuevos compuestos farmaceuticos | |
ATE509931T1 (de) | Azaadamantanester- und carbamatderivate sowie anwendungsverfahren dafür | |
DE502006005053D1 (de) | Spritzbare akustikmassen | |
TN2009000510A1 (en) | Extended release formulation of nevirapine | |
UA86119C2 (ru) | Амидные пролекарства гемцитабина, их композиции и применение | |
ATE552832T1 (de) | Antidepressivum-propharmaka | |
TR201109686T2 (tr) | Olmesartan'ın Farmasötik Bileşimleri. | |
NO20091386L (no) | Fenyloksyanilinderivater | |
CY1113835T1 (el) | Δραση των εκχυλισματων του φυτου cissampelos pareira εναντι του δαγκειου πυρετου |